iShares iBonds Dec 2030 Term $ Corp UCITS ETF (Acc)

PhysicalIndex replication
AccumulatingDistribution policy
0.12 %TER
£490.10M Fund size
514Number of positions
— TD
8.15 %Top 10 share
USDCurrency
3SRI

Current price

£85.82
19 Nov 2026
1D
1W
1M
3M
6M
1Y
3Y
Max

Description

The Share Class is a share class of a Fund, which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the Bloomberg MSCI December 2030 Maturity USD Corporate ESG Screened Index, the Fund’s benchmark index (Index). The Share Class, via the Fund, is passively managed and aims to invest so far as possible and practicable in the fixed income (FI) securities (such as bonds) that make up the Index and comply with its credit rating requirements. The Index is designed to measure the performance of investment grade, taxable fixed rate, US Dollar denominated corporate bonds which mature between 01/01/30 and 02/12/30 and excludes issuers based on the index provider's ESG and other exclusionary criteria. If the credit ratings of the FI securities are downgraded below investment grade or where securities no longer meet the ESG criteria, the Fund may continue to hold these until they cease to form part of the Index and it is practicable to sell the position. It is a term of investment in the Fund that Shareholders on 02/12/30 will have their Shares redeemed without further notice or Shareholder approval on 03/12/30. The Index is market capitalisation weighted, with a 3% cap on any one issuer, and a pro rata distribution of any excess weight across the Index. The Index rebalances monthly until one year prior to maturity when rebalancing ceases except to remove securities at the end of each month which have been downgraded below investment grade or where securities no longer meet the ESG criteria. Market capitalisation is the market value of the outstanding bond issuance. The Index applies screens which exclude issuers that are involved in the following business lines/activities: tobacco, nuclear weapons, civilian firearms, controversial weapons, thermal coal mining, generation of thermal coal power, oil sands, conventional weapons and weapons systems/components/support systems/services. The Fund uses optimising techniques to achieve a similar return to its Index. These techniques may include the strategic selection of certain securities that make up the Index or other securities which provide similar performance to certain constituent securities. These may also include the use of financial derivative instruments (FDIs) (i.e. investments the prices of which are based on one or more underlying assets). The Fund may use FDIs for direct investment purposes. The use of FDIs is expected to be limited. The Fund may also engage in short-term secured lending of its investments to certain eligible third parties to generate additional income to off-set the costs of the Fund. Recommendation: This Fund is suitable for medium to long term investment, though the Fund may also be suitable for shorter term exposure to the Index. This Fund may not be appropriate for investors who plan to withdraw their money before 02/12/30. Your shares will be accumulating shares (i.e. income will be included in their value). Your shares will be denominated in US Dollar, the Fund's base currency. The shares are listed on one or more stock exchanges and may be traded in currencies other than their base currency. The performance of your shares may be affected by this currency difference. In normal circumstances, only authorised participants (e.g. select financial institutions) may deal in shares (or interests in shares) directly with the Fund. Other investors can deal in shares (or interests in shares) daily through an intermediary on stock exchange (s) on which the shares are traded. Indicative net asset value is published on relevant stock exchanges websites. For more information on the Fund, Share Class, risks and charges, please see the Fund's prospectus, available on the product pages at www.blackrock.com

Return

Here you can see the performance (incl. distributions) of the iShares iBonds Dec 2030 Term $ Corp UCITS ETF (Acc).

Period Perfor­mance
1 Week+0.83 %
1 Month+1.75 %
3 Months+2.18 %
6 Months+1.79 %
1 Year+0.42 %
3 Years—
5 Years—
10 Years—
Since inception +8.63 %(3.41 % p.a.)
Year Perfor­mance
YTD+1.91 %
2025-4.50 %
2024+9.00 %
2023—
2022—
2021—
As of: 18 Nov 2026. Performance displayed in GBP

Master data

Key master data for the iShares iBonds Dec 2030 Term $ Corp UCITS ETF (Acc)

Total expense ratio (TER) 0.12 %
Index replication Physical
Replication method Optimized
Distribution policy Accumulating
Fund size £490.10M
Fund launch 31 May 2024
Fund currency USD
Currency hedging No 
Fund domicileIrland
Risk indicator (SRI)
3 · medium-low risk class

Risk metrics

Key risk and analysis metrics for the iShares iBonds Dec 2030 Term $ Corp UCITS ETF (Acc)

Volatility
5.11 % 1 Year
— 3 Years
— 5 Years
max. Drawdown
-2.01 % 1 Year
— 3 Years
— 5 Years
Sharpe Ratio
0.46 1 Year
— 3 Years
— 5 Years
XLM
—

Information about the Bloomberg MSCI Dec 2030M USD C ESG S USD Index

Index name Bloomberg MSCI Dec 2030M USD C ESG S USD (1)
Included securities 518
Stock positions 0
Bond positions 514
Cash and other positions 4

More ETFs tracking the Bloomberg MSCI Dec 2030M USD C ESG S USD Index

Here you can find alternative index funds for the Bloomberg MSCI Dec 2030M USD C ESG S USD.

Frequently asked questions

Here you will find all answers to your questions about the iShares iBonds Dec 2030 Term $ Corp UCITS ETF (Acc)

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.